Colorectal cancer screening in Slovakia

Czech version

Authors: A. Orságh ^1,2; R. Novota ²; A. Štrbavý ²; J. Trautenberger Ricová ²
Authors‘ workplace: Gastroenterologické oddelenie, Národný onkologický ústav, Bratislava ¹; Národný onkologický inštitút, Bratislava ²
Published in: Gastroent Hepatol 2025; 79(5): 373-383
Category: Original Article
doi: https://doi.org/10.48095/ccgh2025373

Overview

Colorectal cancer (CRC) is one of the most common oncological diseases worldwide. The Slovak Republic ranks among the countries with high incidence of this malignancy. Organized screening reduces both the incidence and mortality of colorectal cancer. In recent years, a decline in age-standardized incidence and mortality rates has been observed in Slovakia. Colorectal cancer screening in Slovakia began in 2004. Since 2021, an active invitation system has been introduced, targeting individuals from the eligible population who have not participated in screening within the past two years. The target population for CRC screening in Slovakia includes individuals aged 50 to 75 years who are at average risk for the disease. Screening is performed either by a biennial immunochemical fecal occult blood test (FIT) in the general practitioner’s office or by a primary screening colonoscopy once every 10 years. Since the implementation of the active invitation system, there has been an increase in the number of FITs performed, as well as in the number of both screening and diagnostic colonoscopies in the target population. The most significant challenge of the CRC screening program in Slovakia is the lack of relevant data to assess its effectiveness and quality assurance.

Keywords:

colorectal cancer – cancer screening – fecal occult blood test – colonoscopy

Sources

1. International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today [online]. Lyon, France: International Agency for Research on Cancer. 2025 [online]. Dostupné z: https: //gco.iarc.fr/today.

2. Suchánek Š, Ambrožová M, Grega T et al. Screening kolorektálního karcinomu v České republice –⁠ minulost, současnost a budoucnost. Gastroent Hepatol 2024; 78 (5): 378–387. doi: 10.48095/ccgh2024378.

3. NCZI. Výskyt zhubných nádorov v Slovenskej republike za roky 1996–2022. 2024 [online]. Dostupné z: https: //app.powerbi.com/view?r=eyJrIjoiMzAzMjIzZTctZmQwNi00NWEwLWE5YjM tNGNlOTNkZmIxNjJiIiwidCI6IjMxMGJhNTk1LTAxM2MtNDAyZC05ZWYyLWI1N2Q1ZjFkY2Q2MyIsImMiOjl9.

4. IARC. Against cancer: cancer screening in the European Union: report on the implementation of the Council Recommendation on cancer screening. 2017 [online]. Dostupné z: chrome-extension: //efaidnbmnnnibpcajpcglclefindmkaj/https: //health.ec.europa.eu/system/files/2017-05/2017_cancerscreening_2ndreportimplementation_en_0.pdf.

5. Karsa L, Patnick J, Segnan N et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 2010 [online]. Dostupné z: chrome-extension: //efaidnbmnnnibpcajpcglclefindmkaj/https: //www.kolorektum.cz/res/file/legislativa/crc-screening-guidelines-ec-2011-02-03.pdf.

6. Hrčka R., Bátovský M. Šesť rokov trvania Národného programu skríningu kolorektálneho karcinómu na Slovensku. Gastroent Hepatol 2018; 72 (5): 415–420. doi: 10.14735/amgh2018415.

7. Národný onkologický ústav. Štatút Národného onkologického inštitútu. 2020 [online]. Dostupné z: https: //www.noisk.sk/files/2020/2020-07-06-statut-noi-2-vydanie-sk.pdf.

8. Kutáková Ľ. Predbežné vyhodnotenie 1. fázy populačného skríningu kolorektálneho karcinómu. 2020 [online]. Dostupné z: 2020-11-12-predbezne-vysledky-prvej-fazy-skriningu-kolorektalneho-karcinomu.pdf.

9. Hrčka R, Hlavatý T. Štandardný postup na výkon prevencie kolorektálneho karcinómu –⁠ metódou populačného skríningu. 2020 [online]. Dostupné z: https: //www.health.gov.sk/Zdroje?/Sources/dokumenty/SDTP/standardy/Skriningove_standardy/Populacny_skrining_kolorektalneho_karcinomu_-_1_revizia.pdf.

10. Tóth J, Hlavatý T, Orságh A. Štandardný postup pre výkon prevencie skríningu kolorektálneho karcinómu v populácii so zvýšeným rizikom kolorektálneho karcinómu. 2021 [online]. Dostupné z: chrome-extension: //efaidnbmnnnibpcajpcglclefindmkaj/https: //www.noisk.sk/files/2022/2022-02-06-standardny-postup-pre-vykon-prevencie-skrining-kk-high-risk.pdf.

11. Národný onkologický inštitút. Stav onkologických skríningov na Slovensku: správa za rok 2024. 2025 [online]. Dostupné z: https: //www.noisk.sk/files/2025/2025-06-12-noi-rocenka-skriningy-2024-sk.pdf.

12. NCZI. Onkologické skríningy v Slovenskej republike za roky 2021–2024. 2025 [online]. Dostupné z: https: //app.powerbi.com/view?r=eyJrIjoiMTc0MjkyNjAtMTYzNy00MTI2LTk3 MjUtN2Y2OGNlYjU5NGNjIiwidCI6IjMxMGJhNTk1LTAxM2MtNDAyZC05ZWYyLWI1N2Q1ZjFkY2Q2MyIsImMiOjl9.

ORCID autorov

A. Orságh 0009-0005-2575-5455,

J. Trautenberger Ricová 0000-0002-7620-2157.

Doručené/Submitted: 28. 7. 2025

Prijaté/Accepted: 27. 8. 2025

Korešpondenčný autor

MUDr. Andrej Orságh

Gastroenterologické oddelenie

Národný onkologický ústav

Klenová 1

833 10 Bratislava

andrej.orsagh@nou.sk